Market Size of North America Pharmaceutical Packaging Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 8.30 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
North America Pharmaceutical Packaging Market Analysis
The North America pharmaceutical packaging market is expected to reach a CAGR of 8.3% during the forecast period 2020 - 2025. The growing significance of modern packaging in the pharmaceutical industry has led to brands exploiting the potential of distinctive flexible packaging design to stand out from the rest of their competition and to increase profitability.
- Apart from the basic requirement of protecting the drug, the pack also needs to be appealing and distinct enough to promote itself. Thus, the aesthetic appeal of medical packaging further aids in this factor.
- Blister packs witnessed an increased adoption as they enable improved patient compliance and are easily customized to product design due to the availability of a broad range of materials and multiple configuration options.
- Moreover, the growing demand for packaging that is tamper-evident has driven the demand for blister packaging, which also comprises features, such as enhanced barrier protection and reduced weight of the packaging.
- Flexible pharmaceutical packaging products, such as pouches are used to pack medical devices and supplies, diagnostic reagents, and pharmaceutical drugs. Government regulations have created new challenges for the pharmaceutical and medical device sectors within the last decade. This has driven packaging manufacturers to change their production processes, to meet the demand for high production speed and ensure flexibility and safety in packaging products, while complying with FDA regulations.
- The recent COVID-19 outbreak has provided further impetus to the growth of the fast-growing vaccine industry. For instance, Sanofi is collaborating with the US government to develop a vaccine for the virus. Similarly, GlaxoSmithKline has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) for a vaccine program. Further various companies are extending their help to support the pharmaceutical manufacturers during a pandemic. For instance, in July 2020, Gerresheimer Group's plants in Europe, America, and Asia, where they are manufactured high-quality standards vials in the pharmaceutical industry has received initial orders for vials for drugs and vaccines against COVID-19.
North America Pharmaceutical Packaging Industry Segmentation
North America is one of the largest regions for the pharmaceutical packaging industry because of its large pharmaceutical manufacturing base and the ability to introduce technological advancements to pharmaceutical packaging. The market study is focused on the trends affecting the market in major countries like the United States and Canada. The study tracks the key market parameters, underlying growth influencers, and major vendors operating in the industry. The study tracks the impact of COVID-19 on the overall pharmaceutical packaging industry and its performance.
Product Type | ||||
| ||||
| ||||
Vials | ||||
Ampoules | ||||
Cartridges and Syringes | ||||
Other Product Types |
Country | |
United States | |
Canada |
North America Pharmaceutical Packaging Market Size Summary
The North America pharmaceutical packaging market is experiencing significant growth, driven by the increasing importance of modern packaging solutions in the pharmaceutical industry. Companies are leveraging innovative flexible packaging designs to differentiate themselves and enhance profitability. The demand for packaging that is not only protective but also aesthetically appealing is on the rise, with blister packs gaining popularity due to their ability to improve patient compliance and offer customization options. The need for tamper-evident packaging has further boosted the adoption of blister packaging, which provides enhanced barrier protection and reduced weight. Flexible packaging products, such as pouches, are also in demand for packing medical devices, diagnostic reagents, and pharmaceutical drugs. Regulatory challenges have prompted packaging manufacturers to adapt their processes to meet the high production speed and safety requirements while complying with FDA regulations. The COVID-19 pandemic has accelerated growth in the vaccine industry, with collaborations among pharmaceutical companies and governments driving demand for packaging solutions.
The United States dominates the North American pharmaceutical packaging market, supported by the presence of major global players like Amcor PLC and Becton, Dickinson, and Company. These companies serve large pharmaceutical firms such as Abbott, Pfizer, Roche, and Novartis, catering to both domestic and international markets. The growing population, particularly among children and the elderly, is expected to drive demand for pharmaceutical syrups and medical devices, respectively, thereby increasing the need for packaging solutions like glass bottles and vials. The market is highly competitive, with players focusing on innovation and customization to differentiate their offerings. Recent advancements include automation in multi-dose prescription fulfillment and FDA-approved packaging solutions for drug delivery. The market's growth is further supported by investments in manufacturing facilities, such as Arglass Yamamura LLC's expansion in Georgia, and initiatives to address costly pharmaceutical imports, which are expected to boost demand for glass packaging in the region.
North America Pharmaceutical Packaging Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Industry Attractiveness - Porter's Five Forces Analysis
-
1.2.1 Bargaining Power of Suppliers
-
1.2.2 Bargaining Power of Consumers
-
1.2.3 Threat of New Entrants
-
1.2.4 Intensity of Competitive Rivalry
-
1.2.5 Threat of Substitute Products
-
-
1.3 Industry Value Chain Analysis
-
1.4 Market Drivers
-
1.4.1 Growing demand for drug delivery devices & Blister packaging market
-
1.4.2 Rise in Medicine Counterfeiting Leading to Advanced Packaging and Labeling
-
-
1.5 Market Restraints
-
1.5.1 Environmental Concerns Related to Raw Materials for Packaging and Price Competition
-
-
-
2. MARKET SEGMENTATION
-
2.1 Product Type
-
2.1.1 Medical Pouches
-
2.1.1.1 Unit-dose
-
2.1.1.2 Multi-dose
-
-
2.1.2 Blister Packs
-
2.1.2.1 Unit-dose
-
2.1.2.2 Multi-dose
-
-
2.1.3 Vials
-
2.1.4 Ampoules
-
2.1.5 Cartridges and Syringes
-
2.1.6 Other Product Types
-
-
2.2 Country
-
2.2.1 United States
-
2.2.2 Canada
-
-
North America Pharmaceutical Packaging Market Size FAQs
What is the current North America Pharmaceutical Packaging Market size?
The North America Pharmaceutical Packaging Market is projected to register a CAGR of 8.30% during the forecast period (2024-2029)
Who are the key players in North America Pharmaceutical Packaging Market?
Amcor PLC, Sonoco Products Co, Winpak Ltd., Sealed Air Corporation and Omnicell, Inc. are the major companies operating in the North America Pharmaceutical Packaging Market.